- Home
- BBIO vs NARI Comparison
BBIO vs NARI Comparison
Compare BBIO & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- NARI
- Stock Information
- Founded
- BBIO 2015
- NARI 2011
- Country
- BBIO United States
- NARI United States
- Employees
- BBIO N/A
- NARI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- NARI Medical/Dental Instruments
- Sector
- BBIO Health Care
- NARI Health Care
- Exchange
- BBIO Nasdaq
- NARI Nasdaq
- Market Cap
- BBIO 5.6B
- NARI 4.7B
- IPO Year
- BBIO 2019
- NARI 2020
- Fundamental
- Price
- BBIO $36.85
- NARI N/A
- Analyst Decision
- BBIO Strong Buy
- NARI Hold
- Analyst Count
- BBIO 12
- NARI 12
- Target Price
- BBIO $52.27
- NARI $69.22
- AVG Volume (30 Days)
- BBIO 2.7M
- NARI 1.2M
- Earning Date
- BBIO 02-20-2025
- NARI 03-03-2025
- Dividend Yield
- BBIO N/A
- NARI N/A
- EPS Growth
- BBIO N/A
- NARI N/A
- EPS
- BBIO N/A
- NARI N/A
- Revenue
- BBIO $221,902,000.00
- NARI $574,498,000.00
- Revenue This Year
- BBIO $2,306.75
- NARI $24.62
- Revenue Next Year
- BBIO N/A
- NARI $18.00
- P/E Ratio
- BBIO N/A
- NARI N/A
- Revenue Growth
- BBIO 2285.27
- NARI 22.41
- 52 Week Low
- BBIO $21.62
- NARI $36.73
- 52 Week High
- BBIO $39.47
- NARI $79.99
- Technical
- Relative Strength Index (RSI)
- BBIO 63.77
- NARI 5.14
- Support Level
- BBIO $35.36
- NARI $79.76
- Resistance Level
- BBIO $39.47
- NARI $79.99
- Average True Range (ATR)
- BBIO 1.93
- NARI 0.07
- MACD
- BBIO 0.26
- NARI -5.93
- Stochastic Oscillator
- BBIO 70.79
- NARI 0.00
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.